News
Conference Coverage
Ocrelizumab benefit confirmed in older patients with MS
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
Latest News
AI detects hidden, potentially curable pancreatic cancers
"Artificial intelligence model could mitigate the inadequacies of imaging and the diagnostic errors in interpretation," the authors wrote.
News
GLP-1 agonists linked to higher risk for rare but serious GI complications
Investigators say their findings are not about scaring people off the weight-loss drugs, but instead about increasing awareness that these...
Latest News
What the first authorized DNA cancer risk test can and can’t tell you
The test can identify genetic variants that increase an individual’s risk of certain cancers and help identify potential cancer-related hereditary...
News
Alert! A decade of type 2 diabetes shortens life by 3.5 years
“I personally think the findings show that we should treat cardiovascular risk factors more aggressively in people diagnosed with [type 2]...
Conference Coverage
Confirmed: Intermittent use of benzodiazepines is the safest option
“We’ve always known that there was a problem, but there haven’t been high-quality epidemiological studies like this that allowed us to say what...
Conference Coverage
Esketamine bests quetiapine for severe depression in head-to-head trial
“These patients are not resistant, they just have resistance to monoaminergic drugs.”
News
Proton pump inhibitors linked to increased dementia risk
“The association between PPI use and dementia was unambiguously largest among the youngest cases of dementia.”
News
Breast, GYN Cancers Diagnosed at Lower Ages in VA Than Community
A new report offers a picture of patients seeking care for breast and gynecological cancers within the US Department of...
Latest News
Growing ‘tranq’ threat poses challenges for PCPs
“Xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier.”